What is the priority blood work for a patient suspected of having syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Priority Blood Work for Suspected Syphilis

For patients suspected of having syphilis, the priority blood work should include both nontreponemal (RPR or VDRL) and treponemal tests, with the nontreponemal test typically performed first in the traditional algorithm. 1

Diagnostic Algorithm

Initial Testing

  1. Nontreponemal test (first-line screening):

    • Rapid Plasma Reagin (RPR) or
    • Venereal Disease Research Laboratory (VDRL) test
  2. Treponemal-specific test (confirmation if nontreponemal test is positive):

    • Fluorescent Treponemal Antibody Absorption (FTA-ABS)
    • T. pallidum Particle Agglutination (TP-PA)

Alternative Approach (Reverse Sequence)

Some laboratories use the reverse sequence algorithm:

  1. Treponemal test first (screening)
  2. Nontreponemal test (if treponemal test is positive)
  3. Second treponemal test (if discordant results)

Test Performance by Stage of Disease

Primary Syphilis

  • Nontreponemal tests have variable sensitivity:
    • RPR: 71-92.7% sensitivity 2
    • VDRL: 50-78.4% sensitivity 2
  • False negatives are common in early primary syphilis

Secondary Syphilis

  • Both tests have excellent sensitivity:
    • RPR: 91-100% sensitivity 2
    • VDRL: 100% sensitivity 2

Latent Syphilis

  • Early latent: VDRL sensitivity 82.1-100% 2
  • Late latent: RPR/VDRL sensitivity 61-75% 2

Special Considerations

HIV Co-infection Testing

  • HIV testing should be performed in all patients with suspected syphilis due to:
    • High co-infection rates
    • Altered presentation in HIV-positive patients
    • Potential impact on treatment and follow-up 1

Additional Testing Based on Clinical Presentation

  • For suspected neurosyphilis: Lumbar puncture for CSF analysis

    • CSF-VDRL (specificity 99%) 3
    • CSF-RPR (specificity 99.3%) 3
    • CSF cell count and protein
  • For pregnant patients: More frequent serologic testing and closer follow-up 1

Common Pitfalls and Caveats

  1. Prozone phenomenon: False-negative results in high-titer specimens

    • Solution: Request dilution testing if clinical suspicion is high
  2. Biological false positives: Can occur in 0.8-1.3% of the general population due to:

    • Autoimmune disorders
    • Pregnancy
    • IV drug use
    • Viral infections (HCV, HIV) 1
  3. Test selection issues:

    • RPR and VDRL titers are not directly comparable
    • Switching between test types during follow-up should be avoided
  4. Seronegative window period:

    • Early primary syphilis may have negative serologic tests
    • Consider direct detection methods (dark-field microscopy or PCR) for genital lesions

Follow-up Testing

After treatment, quantitative nontreponemal tests should be performed at:

  • 3 months
  • 6 months
  • 9 months
  • 12 months

A four-fold decline in titer (e.g., 1:32 to 1:8) indicates adequate treatment response 1, 4.

Conclusion

The combination of nontreponemal and treponemal tests is essential for accurate diagnosis of syphilis, with test selection guided by clinical presentation and stage of disease. High-titer RPR (≥1:32) is associated with increased risk of neurosyphilis, particularly in HIV-infected patients with CD4+ counts ≤350 cells/μL 5.

References

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and management of syphilis.

American family physician, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.